About this item

Issue date:
23 September 2024
Status:
Current
Corporate Author:
Health New Zealand | Te Whatu Ora,
Type:
Research,
Topic:
COVID-19, Immunisation,

A study was conducted to explore individuals’ experiences by surveying people diagnosed with myocarditis and/or pericarditis following vaccination with Comirnaty. The study was not designed to confirm or investigate whether the vaccination event was the cause or related to the myocarditis or pericarditis. This report describes how the study was conducted and the results from the participant surveys.

Download: Report - DOCX, 781 KB

Long-term outcomes of myocarditis and pericarditis following vaccination with Comirnaty (Pfizer/BioNTech COVID-19 vaccine)

Download: Report - PDF, 996 KB

Long-term outcomes of myocarditis and pericarditis following vaccination with Comirnaty (Pfizer/BioNTech COVID-19 vaccine)

Download: Summary - PDF, 339 KB

Long-term outcomes of myocarditis and pericarditis following vaccination with Comirnaty (Pfizer/BioNTech COVID-19 vaccine)

Download: Summary - DOCX, 987 KB

Long-term outcomes of myocarditis and pericarditis following vaccination with Comirnaty (Pfizer/BioNTech COVID-19 vaccine)